Form 4: Encompass Health Director Greg D. Carmichael Acquires Additional Shares Through Dividend Reinvestment

Director Greg D. Carmichael acquired 25 additional shares of Encompass Health Corp through a dividend reinvestment program.

Summary

• Greg D. Carmichael, a director at Encompass Health Corp, acquired 25 shares of common stock on January 15, 2025.
• These shares were acquired through a dividend reinvestment program, where dividend payments are used to purchase additional shares.
• The dividend payment was $0.17 per share, and the closing price of the stock on the dividend payment date was $93.61.
• The acquisition increased Carmichael's total holdings to 17,137 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation and dividend reinvestment, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of shares through dividend reinvestment demonstrates a continued investment by a director in the company.
• The dividend payment of $0.17 per share indicates a return of capital to shareholders.

Industry Context

This is a routine transaction related to director compensation and dividend reinvestment, which is common practice for publicly traded companies.

Comparison to Industry Standards

• Dividend reinvestment programs are a common practice among publicly traded companies, allowing shareholders to automatically reinvest dividends into additional shares.
• The specific terms of the RSU awards and dividend reinvestment are typical for director compensation packages in similar companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates continued investment by a director in the company.

Key Dates

Keywords

Encompass Health, Director, Dividend Reinvestment, Share Acquisition, Form 4, Greg D. Carmichael, Stock Dividend